Related Experiment Videos
Sarcomas of soft tissue and bone
1Division of Clinical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
Cancer
|August 1, 1991
Summary
Sarcomas are cancers originating from mesenchymal tissues. Tumor grade and location are key prognostic factors for soft tissue sarcomas, influencing treatment and outcomes.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sarcomas originate from mesenchymal structures throughout the body.
- Risk factors include radiation, toxic exposures, and genetic conditions.
- Soft tissue sarcomas are distinct from bone sarcomas.
Purpose of the Study:
- To summarize the prognostic variables and treatment modalities for soft tissue sarcomas.
- To highlight the importance of tumor grade and location in managing these cancers.
Main Methods:
- Review of existing literature on sarcoma classification, prognosis, and treatment.
- Analysis of prognostic indicators such as tumor grade and location.
- Evaluation of treatment strategies including surgery, radiation, and chemotherapy.
Main Results:
- Tumor grade is the most critical prognostic factor for localized soft tissue sarcoma.
- Low-grade tumors often cured by surgery; high-grade tumors have significant recurrence and metastasis rates.
- Treatment varies by subtype (e.g., rhabdomyosarcoma) and location influences resectability.
Conclusions:
- Wide surgical excision is curative for low-grade soft tissue sarcomas.
- Radiation therapy improves local control when combined with conservative surgery.
- Adjuvant chemotherapy is established for specific pediatric sarcomas (rhabdomyosarcoma) and bone sarcomas (osteosarcoma, Ewing's sarcoma) but remains unproven for most adult soft tissue sarcomas.